The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation
The Effect of an Online Acceptance and Commitment Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation: a Randomized Controlled Trial Enhanced With a Single-case Experimental Design
1 other identifier
interventional
192
1 country
1
Brief Summary
This trial aimed to test internet-based Acceptance and Commitment Therapy (ACT) intervention to induce a meaning-making process in cancer patients following hematopoietic cell transplantation (HCT). ACT includes identifying personal values and engaging in activities consistent with these values, developing acceptance, as well as focusing on the present moment or performing activities with greater awareness. In total, 192 patients following the first (autologous or allogeneic) HCT will be randomly assigned in equal numbers to either the ACT intervention or an education session. Participants in both conditions will take part in 14-day training (about 5-10 minutes a day). The outcomes will be measured at baseline, during the intervention, immediately, 1 month, and 3 months after the intervention. Moreover, 6-9 additional participants will be randomly assigned to pre-intervention measurement length (1-3 weeks) before completing ACT intervention, followed by 7-day observations at the 2nd and 3rd post-intervention measure. The researchers hypothesized that ACT intervention would foster a meaning-making process and thus reduce distress induced by the discrepancy between global and situational meaning as compared to education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedStudy Start
First participant enrolled
March 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMay 16, 2024
May 1, 2024
1.7 years
January 25, 2024
May 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distress (Global Meaning Violation Scale; GMVS)
The GMVS measures meaning-related distress. It is a 12-item questionnaire (from the original, the item "health" was removed due to the context of the study) that assesses belief (5 items) and goal violations (7 items) in response to stressors on a 5-point scale ranging from 1 (not at all) to 5 (very much). The overall score is calculated by summing the scores of all 12 items, with a possible range of 12-60. Higher scores indicate greater meaning-related distress (greater global meaning violation).
Change from baseline to immediately, 1 month and 3 months after intervention
Secondary Outcomes (17)
Illness perception (Brief-Illness Perception Questionnaire; B-IPQ)
Change from baseline to immediately, 1 month and 3 months after intervention
Global meaning (Meaning in Life Questionnaire; MLQ)
Change from baseline to immediately, 1 month and 3 months after intervention
Psychological flexibility (Comprehensive Assessment of Acceptance and Commitment Therapy Processes-9; CompACT-9)
Change from baseline to immediately, 1 month and 3 months after intervention
Coping self-efficacy (Coping Self-Efficacy Scale; CSE - selected items)
Change from baseline to immediately, 1 month and 3 months after intervention
Deliberate meaning-making (Core Beliefs Inventory; CBI)
Change from baseline to immediately, 1 month and 3 months after intervention
- +12 more secondary outcomes
Study Arms (2)
ACT intervention
EXPERIMENTALParticipants in the ACT intervention arm will learn new adaptive ways to cope with difficulties (including difficult thoughts or feelings).
Education
OTHERParticipants in the Education arm will become familiar with post-HCT recommendations. This will be a minimally enhanced usual care.
Interventions
ACT intervention will start on the second day after hospital discharge and will take 14 days (+ day 0 with organizational information). Each day, participants will receive a web-based intervention consisting of educational and practical tasks/activities. Participants will learn to recognize moments of choice (actions that lead towards values or away from them) and to use attention flexibly to free themselves from the power of thoughts, to open up and accept emotions, and to be able to determine what is important and take action in line with values. All of the tasks will be available in written form and audio. The ACT intervention is built from standard ACT exercises.
Education will start on the second day after hospital discharge and will take 14 days (+ day 0 with organizational information). Each day, participants will receive information about post-transplant prescriptions along with exercises to support the implementation. Participants will learn about nutrition, personal hygiene, preventing infections, coping with fatigue, resuming activity, rest and sleep, engaging in social interactions, and sexual health. The content is prepared based on available guides for HCT recipients.
Eligibility Criteria
You may qualify if:
- Qualification for the first autologous or allogeneic HCT due to hematologic malignancies or solid tumors
- Age ≥ 18 years
- Signed written informed consent
- Ability to read and write in Polish
- Daily access to the Internet by computer and/or mobile device
You may not qualify if:
- Major psychiatric or cognitive disorder that would impede providing informed consent and study participation
- Inability to cooperate and give informed consent
- Hearing, seeing, or movement impairment that precludes participation
- Current participation in any form of psychotherapy
- No access to the Internet
- No access to a computer and/or mobile device
- Inability to use a computer and/or mobile device and the Internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Department of Bone Marrow Transplantation and Oncohematology
Gliwice, 44-102, Poland
Related Publications (1)
Kroemeke A, Dudek J, Kijowska M, Owen R, Sobczyk-Kruszelnicka M. The effect of an online acceptance and commitment intervention on the meaning-making process in cancer patients following hematopoietic cell transplantation: study protocol for a randomized controlled trial enhanced with single-case experimental design. Trials. 2024 Jun 18;25(1):392. doi: 10.1186/s13063-024-08235-1.
PMID: 38890709DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aleksandra Kroemeke, PhD
SWPS University (University of Social Sciences and Humanities)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Associate professor
Study Record Dates
First Submitted
January 25, 2024
First Posted
February 20, 2024
Study Start
March 6, 2024
Primary Completion
December 1, 2025
Study Completion
April 1, 2026
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Beginning 3 months after publication without an end date.
- Access Criteria
- All those who will have an open link.
The full protocol, dataset, statistical codes, and outputs will be made available at the Open Science Framework (OSF). Anonymized participant-level datasets will be publicly available, however, without demographics and clinical data due to privacy or ethical restrictions (the possibility of identification of participants). The data will be stored for at least 5 years after the end of the project unless other regulations lengthen the need to store the data or it is not necessary due to other reasons (e.g. documentation of research results).